Cargando…
To filter blood or universal leukoreduction: what is the answer?
The safety of the blood supply has been a concern over the past 20–30 years because of the transmission of infectious diseases. Blood is still routinely tested for viruses, and leukoreduction is an effective strategy to reduce the transmission of cell-associated viruses. Clinically, the benefits of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226148/ https://www.ncbi.nlm.nih.gov/pubmed/15196319 http://dx.doi.org/10.1186/cc2453 |
_version_ | 1782217569277575168 |
---|---|
author | Shapiro, Marc J |
author_facet | Shapiro, Marc J |
author_sort | Shapiro, Marc J |
collection | PubMed |
description | The safety of the blood supply has been a concern over the past 20–30 years because of the transmission of infectious diseases. Blood is still routinely tested for viruses, and leukoreduction is an effective strategy to reduce the transmission of cell-associated viruses. Clinically, the benefits of leukoreduction include decreases in transfusion reactions, HLA alloimmunization, infections, fever episodes, and antibiotic use. Although leukoreduction will add cost to a unit of blood, projections indicate that leukoreduced blood will become the standard of care. |
format | Online Article Text |
id | pubmed-3226148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32261482011-11-30 To filter blood or universal leukoreduction: what is the answer? Shapiro, Marc J Crit Care Review The safety of the blood supply has been a concern over the past 20–30 years because of the transmission of infectious diseases. Blood is still routinely tested for viruses, and leukoreduction is an effective strategy to reduce the transmission of cell-associated viruses. Clinically, the benefits of leukoreduction include decreases in transfusion reactions, HLA alloimmunization, infections, fever episodes, and antibiotic use. Although leukoreduction will add cost to a unit of blood, projections indicate that leukoreduced blood will become the standard of care. BioMed Central 2004 2004-06-14 /pmc/articles/PMC3226148/ /pubmed/15196319 http://dx.doi.org/10.1186/cc2453 Text en Copyright ©2004 BioMed Central Ltd |
spellingShingle | Review Shapiro, Marc J To filter blood or universal leukoreduction: what is the answer? |
title | To filter blood or universal leukoreduction: what is the answer? |
title_full | To filter blood or universal leukoreduction: what is the answer? |
title_fullStr | To filter blood or universal leukoreduction: what is the answer? |
title_full_unstemmed | To filter blood or universal leukoreduction: what is the answer? |
title_short | To filter blood or universal leukoreduction: what is the answer? |
title_sort | to filter blood or universal leukoreduction: what is the answer? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226148/ https://www.ncbi.nlm.nih.gov/pubmed/15196319 http://dx.doi.org/10.1186/cc2453 |
work_keys_str_mv | AT shapiromarcj tofilterbloodoruniversalleukoreductionwhatistheanswer |